Anti-TGFB3/TGF-beta-3 antibody [SAA0445] {FITC} (STJA0028152)

SKU:
STJA0028152-100
£284.50
Free Shipping
Processing The item has been added

Short Description :Mouse monoclonal Transforming Growth Factor Beta-3 Proprotein Cleaved Into-Latency-Associated Peptide antibody for use in ELISA and FC in human samples. Datasheet included with dilution recommendations, and related reagents.
Applications:ELISA/FC
Host:Mouse
Reactivity:Human
Note:STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO) MUST NOT BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS
Clonality :Monoclonal
Clone ID :SAA0445
Isotype:IgG2ak
Conjugation:FITC
Concentration:05 mg/mL
Purification:Purified
Formulation:PBS pH 7.4, 50% glycerol, 0.05% proclin300
Storage Instruction:Store at 4°C for 12 months Protect from light Do not freeze
Gene Symbol:TGFB3
Gene ID:7043
Uniprot ID:TGFB3_HUMAN
Function Transforming growth factor beta-3 proprotein: Precursor of the Latency-associated peptide (LAP) and Transforming growth factor beta-3 (TGF-beta-3) chains, which constitute the regulatory and active subunit of TGF-beta-3, respectively. Latency-associated peptide: Required to maintain the Transforming growth factor beta-3 (TGF-beta-3) chain in a latent state during storage in extracellular matrix. Associates non-covalently with TGF-beta-3 and regulates its activation via interaction with 'milieu molecules', such as LTBP1 and LRRC32/GARP, that control activation of TGF-beta-3. Interaction with integrins results in distortion of the Latency-associated peptide chain and subsequent release of the active TGF-beta-3. Transforming growth factor beta-3: Multifunctional protein that regulates embryogenesis and cell differentiation and is required in various processes such as secondary palate development. Activation into mature form follows different steps: following cleavage of the proprotein in the Golgi apparatus, Latency-associated peptide (LAP) and Transforming growth factor beta-3 (TGF-beta-3) chains remain non-covalently linked rendering TGF-beta-3 inactive during storage in extracellular matrix. At the same time, LAP chain interacts with 'milieu molecules', such as LTBP1 and LRRC32/GARP that control activation of TGF-beta-3 and maintain it in a latent state during storage in extracellular milieus. TGF-beta-3 is released from LAP by integrins: integrin-binding results in distortion of the LAP chain and subsequent release of the active TGF-beta-3. Once activated following release of LAP, TGF-beta-3 acts by binding to TGF-beta receptors (TGFBR1 and TGFBR2), which transduce signal.
Protein Name Transforming Growth Factor Beta-3 Proprotein Cleaved Into - Latency-Associated Peptide
Lap - Transforming Growth Factor Beta-3
Tgf-Beta-3
Database Links Reactome: R-HSA-114608
Reactome: R-HSA-2129379
Reactome: R-HSA-2173789
Reactome: R-HSA-3000178
Cellular Localisation Latency-Associated Peptide: Secreted
Extracellular Space
Extracellular Matrix
Transforming Growth Factor Beta-3: Secreted
Alternative Antibody Names Anti-Transforming Growth Factor Beta-3 Proprotein Cleaved Into - Latency-Associated Peptide antibody
Anti-Lap - Transforming Growth Factor Beta-3 antibody
Anti-Tgf-Beta-3 antibody
Anti-TGFB3 antibody

Information sourced from Uniprot.org